Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Custom Media Event: ESG Summit
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Virtual Health
    • - Future of Healthcare Staffing
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
October 20, 2012 01:00 AM

Under scrutiny

More control of compounding pharmacies sought

Jaimy Lee
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    AP PHOTO
    FDA investigators visit the facility that compounded the steroid injections; federal officials last week confirmed the company as the source of a meningitis outbreak.

    Compounding pharmacies may face more regulations as lawmakers and stakeholders continue to question federal and state oversight of the Massachusetts pharmacy confirmed as responsible for the multistate fungal meningitis outbreak.

    On Oct. 16, the Food and Drug Administration raided the New England Compounding Center, the Framingham, Mass.-based compounding pharmacy that distributed the contaminated steroid injections.

    As of Oct. 19, there had been 268 cases of fungal meningitis, 21 deaths as a result of the outbreak and three peripheral joint infections. Sixteen states have reported infections.

    NECC shut down operations this month and recalled more than 2,000 products, while Ameridose, a Westborough, Mass.-based provider of sterile admixing and repackaging services that shares ownership with NECC, announced plans to cease production and shipping of its products. Government officials said last week that they had confirmed that the fungus responsible for the outbreak was found in unopened vials of preservative-free methylprednisolone acetate from NECC.

    Pharmacists and providers say that compounders fill a widening gap in the current system. Strict sterile compounding regulations in effect since 2004 have compelled many hospitals to outsource compounding. Compounding pharmacies also have served as a source of drugs in short supply.

    “The number of compounding pharmacies has grown significantly over the last few years,” said Linda Bentley, a lawyer and chairwoman of Mintz Levin's FDA practice group. “Going forward, there's going to have to be closer cooperation between FDA and all the state boards of pharmacy.”

    State boards of pharmacy have oversight of pharmacies. The FDA, which regulates drug manufacturing, has attempted to inspect and regulate compounding pharmacies, including NECC, that were suspected of manufacturing, but many of the agency's efforts failed when compounders took their cases to court.

    The Massachusetts Board of Pharmacy and the FDA have come under scrutiny for their oversight of NECC, prompting the House Committee on Energy and Commerce to request information last week about past FDA inspections of NECC facilities and communications between the agency and NECC.

    “The FDA will continue to act within its existing authorities to protect public health and help ensure the safety of medical products,” an FDA spokeswoman said in a statement. “Once the immediate crisis is contained, the FDA is committed to working with Congress, compounders, the states and all other stakeholders to strengthen the system to prevent tragedies like this from happening again.”

    Although lawmakers have said they will introduce legislation that would give the FDA greater authority to oversee compounding pharmacies, others have said it is still unclear whether there is a need for federal oversight.

    In an Oct. 12 statement, the American Society of Health-System Pharmacists said any organization that manufactures medications without a prescription should be registered with the FDA as a manufacturer.

    However, how the FDA and state boards of pharmacies view the line between compounding and manufacturing is unclear. There should be a “better understanding of compounding and manufacturing,” said Cynthia Reilly, ASHP's director of practice development division. “Defining that has been a gray area.”

    The FDA spokeswoman said compounded drugs can serve an important public health need, but when compounded drugs are not prepared properly, they can pose potential health risks. “When such compounding occurs on a large scale, more patients are exposed to those risks,” she said.

    Of the roughly 3,000 pharmacies that provide sterile compounding in the U.S., 162 have been accredited by the Pharmacy Compounding Accreditation Board, a not-for-profit that was formed by eight pharmacy organizations and accredited its first pharmacy in 2006. NECC is not accredited.

    The PCAB standards meet or exceed the U.S. Pharmacopeia regulations, considered the industry benchmark on sterile compounding, said Alex Chervinsky, owner of HMCompounding, a PCAB-accredited pharmacy in Brooklyn, N.Y. “The industry itself saw the need for this nonprofit organization,” he said.

    The board conducts site visits every three years and charges an annual fee of $1,500 to $5,000 to pharmacies seeking accreditation.

    Three of PCAB's employees, including its executive director, are employees of the American Pharmacists Association, according to the accrediting board's 2011 tax filing. A spokeswoman for the APhA said in an e-mail that the other founding organizations are also represented on PCAB's board, and that the APhA serves as its payroll administrator.

    The meningitis outbreak has led to increased interest in accreditation, said Joe Cabaleiro, PCAB's executive director. When asked why more compounding pharmacies haven't pursued accreditation, he said the payers, prescribers and patients haven't demanded it. “The market hasn't demonstrated the need for accreditation.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Amwell logo_edited_i.jpg
    Amwell tapped for CVS Health's virtual care platform
    Myra Davis
    Q&A with Myra Davis of Texas Children's Hospital: ‘Innovation is everyone’s responsibility’
    Sponsored Content
    Health IT Strategist (HITS) Newsletter: Sign up for the latest IT and medical technology news delivered 3 days a week (M, W, F).
     
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Transformation Summit
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Virtual Health
        • - Future of Healthcare Staffing
      • Custom Media Event: ESG Summit
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing